Skip to content

Clinical trials

Dermatomyositis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20151
20171
20181
20191
20211
20223
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Chugai Pharmaceutical2
The Hospital for Sick Children2
Allogene Therapeutics1
Corbus Pharmaceuticals Inc.1
McMaster University1
National Cancer Institute (NCI)1
Octapharma1
Priovant Therapeutics, Inc.1
University of Pittsburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis14
Myositis4
Polymyositis4
Autoimmune Diseases3
Lupus Erythematosus, Systemic3
Antiphospholipid Syndrome2
Arthritis, Rheumatoid2
Behcet Syndrome2
Pemphigoid, Bullous2
Purpura, Thrombocytopenic, Idiopathic2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.